A Study to Evaluate the Efficacy and Safety of Dupilumab in Participants With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED) Read more about A Study to Evaluate the Efficacy and Safety of Dupilumab in Participants With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED)
Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study Read more about Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
Prevalence of Carbohydrate Intolerance in Lean and Obese Children Read more about Prevalence of Carbohydrate Intolerance in Lean and Obese Children
Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants Read more about Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants
An Intermediate Access Protocol for Selumetinib for Treatment of Neurofibromatosis Type 1 Read more about An Intermediate Access Protocol for Selumetinib for Treatment of Neurofibromatosis Type 1
Determine the Safety, Tolerability, and Efficacy of MAU868 for the Prevention of BK Virus Infection in Kidney Transplant Recipients Read more about Determine the Safety, Tolerability, and Efficacy of MAU868 for the Prevention of BK Virus Infection in Kidney Transplant Recipients
Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma Read more about Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma
Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA) Read more about Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA)
A 12-Week Placebo-Controlled Study to Investigate the Efficacy, Safety, and Tolerability of RO7017773 in Participants Aged 15-45 Years With Autism Spectrum Disorder (ASD) Read more about A 12-Week Placebo-Controlled Study to Investigate the Efficacy, Safety, and Tolerability of RO7017773 in Participants Aged 15-45 Years With Autism Spectrum Disorder (ASD)